| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 06/04/2013 | US8455511 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 05/30/2013 | WO2013077344A1 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element |
| 05/29/2013 | EP2597098A1 (7h-pyrrolo [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation |
| 05/29/2013 | EP2595995A1 Herbicidal isoxazolo[5,4-b]pyridines |
| 05/29/2013 | CN103124733A Herbicidal isoxazolo[5,4-b]pyridines |
| 05/29/2013 | CN103122006A Fused thiophenes and methods for making and using same |
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors |
| 05/29/2013 | CN101805699B Method for preparing gliocladicillin C and application thereof |
| 05/29/2013 | CN101646674B Indolobenzazepine derivatives for the treatment of hepatitis c |
| 05/29/2013 | CN101090902B Cgrp受体拮抗剂 Cgrp receptor antagonist |
| 05/28/2013 | US8450479 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5-tetrazine-8-carboxylic acid amides and their use |
| 05/28/2013 | CA2575601C Methods for producing compositions comprising hyperpolarized 13c-pyruvate |
| 05/23/2013 | WO2013071698A1 Three-ring pi3k and/or mtor inhibitor |
| 05/23/2013 | US20130131042 Spiroxazolidinone compounds |
| 05/21/2013 | US8445479 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 05/21/2013 | CA2560454C Azaindoles useful as inhibitors of jak and other protein kinases |
| 05/16/2013 | WO2013069762A1 Cyclic azine compound having nitrogen-containing fused aromatic group, method for producing same, and organic electroluminescent element using same as constituent component |
| 05/16/2013 | WO2013068470A1 Inhibitors of phosphodiesterase type 10a |
| 05/16/2013 | WO2013068438A1 Purine derivatives for the treatment of viral infections |
| 05/16/2013 | CA2852604A1 Inhibitors of phosphodiesterase type 10a |
| 05/16/2013 | CA2850448A1 Purine derivatives for the treatment of viral infections |
| 05/15/2013 | EP2592905A1 Compound, charge transporting material and organic electroluminescent element |
| 05/15/2013 | EP2592082A1 Heteroaryl amide analogues as p2x7 antagonists |
| 05/15/2013 | EP2591675A1 Heteroaryl amide derivatives |
| 05/15/2013 | EP2590987A1 Ring-fused 4 -aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
| 05/15/2013 | EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
| 05/15/2013 | CN1863891B Organic compound and organic light emitting device using the same |
| 05/15/2013 | CN103102359A Pyrimidine compounds and application thereof |
| 05/14/2013 | CA2731368C 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| 05/10/2013 | WO2013067277A1 Alkylated piperazine compounds as inhibitors of btk activity |
| 05/10/2013 | WO2013067274A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
| 05/10/2013 | CA2853975A1 Heteroaryl pyridone and aza-pyridone compounds as inhibitors of btk activity |
| 05/10/2013 | CA2853970A1 Alkylated piperazine compounds as inhibitors of btk activity |
| 05/09/2013 | US20130116235 Heteroaryl pyridone and aza-pyridone compounds |
| 05/09/2013 | US20130116233 Novel inhibitor compounds of phosphodiesterase type 10a |
| 05/08/2013 | EP2588484A1 Novel organic compound and electrochromic device including the same |
| 05/08/2013 | EP2588468A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2588455A1 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds |
| 05/08/2013 | CN103097393A Quinoxaline compound |
| 05/08/2013 | CN103097383A Pyrazoloquinoline compound |
| 05/08/2013 | CN103097381A 1, 8-naphthyridines as kinase inhibitors |
| 05/08/2013 | CN103087083A Diketopyrrolopyrrole derivative and preparation method and application thereof |
| 05/08/2013 | CN103087082A Porphyrin-phthalocyanine pentaplet, preparation method and applications thereof |
| 05/02/2013 | WO2013061305A1 Novel purine derivatives and their use in the treatment of disease |
| 05/02/2013 | WO2013060636A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 05/02/2013 | WO2013060179A1 Acyltetrahydro-β-carboline compounds as well as derivatives, applications and preparation methods thereof |
| 05/02/2013 | CA2853826A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/02/2013 | CA2853256A1 Novel purine derivatives and their use in the treatment of disease |
| 05/01/2013 | EP2585468A1 Pyrrolo- pyrazine derivatives useful as inhibitors of atr kinase |
| 05/01/2013 | EP2585461A1 2,4- diaryl - substituted [1,8]naphthyridines as kinase inhibitors for use against cancer |
| 05/01/2013 | CN103073557A Benzophenanthridine alkaloid and application of benzophenanthridine alkaloid in resisting cardiovascular system diseases |
| 05/01/2013 | CN102260257B Pyrazolo[3,4-b]pyridine derivatives and application thereof in white organic light-emitting devices |
| 05/01/2013 | CN102017218B Organic electroluminescent element |
| 04/30/2013 | CA2673249C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 04/25/2013 | WO2013057944A1 Novel spiroindoline compound, and medicinal agent comprising same |
| 04/25/2013 | US20130102589 Novel Compound for the Treatment of Hepatitis C |
| 04/24/2013 | EP2583720A1 Oxazolopyrimidines as Edg-1 receptor agonists |
| 04/24/2013 | EP2582703A1 Heteroaryl imidazolone derivatives as jak inhibitors |
| 04/24/2013 | EP2582699A1 Substituted triazolopyridines |
| 04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
| 04/24/2013 | CN103068828A Triazolopyrazine derivatives |
| 04/24/2013 | CN102015710B Azatricyclic antibiotic compounds |
| 04/23/2013 | US8426402 Benzodiazepine derivatives |
| 04/23/2013 | CA2549954C Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 04/18/2013 | WO2013055987A1 Pyrrolobenzodiazepines and conjugates thereof |
| 04/18/2013 | WO2013053873A1 Pyrrolobenzodiazepines |
| 04/18/2013 | WO2013053872A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| 04/18/2013 | WO2013053871A1 Pyrrolobenzodiazepines |
| 04/18/2013 | WO2013053657A1 Antiviral compounds |
| 04/18/2013 | WO2013024291A3 Therapeutically active fused pyrimidine derivatives |
| 04/18/2013 | US20130096299 Novel cephem derivative |
| 04/18/2013 | US20130096141 Bicyclic heterocycle derivatives and methods of use thereof |
| 04/18/2013 | CA2850373A1 Pyrrolobenzodiazepines and targeted conjugates |
| 04/18/2013 | CA2850371A1 Pyrrolobenzodiazepines and conjugates thereof |
| 04/18/2013 | CA2850264A1 Pyrrolobenzodiazepines |
| 04/18/2013 | CA2850103A1 Pyrrolobenzodiazepines |
| 04/18/2013 | CA2850096A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| 04/18/2013 | CA2847083A1 Antiviral compounds |
| 04/17/2013 | EP2580215A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | CN103044446A Heterocycle quinoline derivatives as well as medicinal salts, preparation method and medicinal application thereof |
| 04/17/2013 | CN103044437A Amphiphilic conjugate nano-particle for treating tumors, as well as preparation method and application of same |
| 04/17/2013 | CN102276803B Polymeric material containing anthracene and pyrrole-pyrrole-dione unit, preparation method thereof and application thereof |
| 04/17/2013 | CN101622248B N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as AXL inhibitors |
| 04/17/2013 | CN101501036B Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 04/16/2013 | CA2486157C Opioid and opioid-like compounds and uses thereof |
| 04/11/2013 | WO2013051597A1 Cephem derivative having catechol group |
| 04/11/2013 | US20130090470 Optically-detectable enzyme substrates and their method of use |
| 04/11/2013 | US20130089512 Heteroaryl imidazolone derivatives as jak inhibitors |
| 04/10/2013 | EP2578644A1 Metal complex dye, photoelectric conversion element and dye-sensitized solar cell |
| 04/10/2013 | EP2578583A1 Fused heterocyclic derivatives and methods of use |
| 04/10/2013 | CN103030654A Micromolecular c-Met protein kinase inhibitor |
| 04/10/2013 | CN103030653A Heteroarylopyrimidine derivative, medicinal salt thereof, methods for preparing heteroarylopyrimidine derivative and medicinal salt thereof and medical applications of heteroarylopyrimidine derivative and medicinal salt thereof |
| 04/10/2013 | CN103030585A Heterocyclic compound, organic light-emitting diode and flat panel display device |
| 04/04/2013 | WO2013045413A1 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 04/04/2013 | DE112011101447T5 Bicarbazol enthaltende Verbindungen für OLEDs Bicarbazol containing compounds for OLEDs |
| 04/03/2013 | EP2574610A1 Inhibitors of human immonodeficiency virus replication |
| 04/03/2013 | CN103025729A Evaporable organically semiconductive material and use thereof in an optoelectronic component |
| 04/03/2013 | CN101374838B 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors |
| 03/28/2013 | WO2013042699A1 Spirobifluorene compound, colorant for photoelectric transducer, and photoelectric transducer using same |
| 03/28/2013 | WO2013042446A1 Organic electroluminescent element, display device, and illumination device |